These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4414543)

  • 1. Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi.
    Prien EL; Gershoff SF
    J Urol; 1974 Oct; 112(4):509-12. PubMed ID: 4414543
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.
    Nutr Rev; 1976 Jan; 34(1):18-20. PubMed ID: 765895
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.
    Rattan V; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Res; 1994; 22(3):161-5. PubMed ID: 7992461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of magnesium oxide and vitamin B6 for the prevention of oxalate urolithiasis].
    Konstantinova OV; Chudnovskaia MV; Ianenko EK; Korolev VV
    Urol Nefrol (Mosk); 1987; (6):12-5. PubMed ID: 3438942
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth studies of calcium oxalate in the presence of various ions and compounds.
    Sutor DJ
    Br J Urol; 1969 Apr; 41(2):171-8. PubMed ID: 4305899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylactic treatment of oxalate calculi].
    Ljunggren E
    Z Urol Nephrol; 1965 Jul; 58(7):507-12. PubMed ID: 5841716
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy in urinary calculi. II. Peroral litholysis and prevention].
    Terhorst B; Melchior H
    Urol Int; 1972; 27(3):230-44. PubMed ID: 5050852
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium oxalate renal stones.
    Prien EL
    Annu Rev Med; 1975; 26():173-9. PubMed ID: 1096755
    [No Abstract]   [Full Text] [Related]  

  • 9. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG; Ahlstrand C; Larsson L
    Urol Res; 1980; 8(4):197-206. PubMed ID: 7222314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.
    Gershoff SN; Prien EL
    Am J Clin Nutr; 1967 May; 20(5):393-9. PubMed ID: 6023850
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of pharmacological prevention of oxalate calculi].
    Terhorst B; Lutzeyer W
    Z Urol Nephrol; 1972 Nov; 65(11):815-25. PubMed ID: 4665913
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P; Nemat S; Rose GA
    Urol Res; 1990; 18(6):393-6. PubMed ID: 2100414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical effects in patients with calcium oxalate stone disease during combined treatment with bendroflumethiazide and magnesium oxide.
    Ahlstrand C; Tiselius HG
    Br J Urol; 1984 Apr; 56(2):125-30. PubMed ID: 6498431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].
    Musialik D; Głuszek J; Pieczyńska A
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):739-42. PubMed ID: 1669148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of long-term pyridoxine administration on serum and urinary values of calculi-forming substances in Ca-oxalate urolithiasis].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Vnitr Lek; 1978 May; 24(5):445-50. PubMed ID: 96593
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperoxaluria and recurrent stone formation apparently cured by short courses of pyridoxine.
    Harrison AR; Kasidas GP; Rose GA
    Br Med J (Clin Res Ed); 1981 Jun; 282(6282):2097-8. PubMed ID: 6788219
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new drug in the therapy of uric acid calculi].
    Frang D; Berényi M; Babics A
    Z Urol Nephrol; 1974 Feb; 67(2):89-92. PubMed ID: 4847955
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.
    Fetner CD; Barilla DE; Townsend J; Pak CY
    J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug dosage protocol for calcium oxalate stone.
    Marickar YM; Salim A
    Urol Res; 2009 Dec; 37(6):353-7. PubMed ID: 19826800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.